Stille AB (STO:STIL)
190.50
-6.00 (-3.05%)
Mar 25, 2026, 3:06 PM CET
Stille AB Market Cap
Stille AB has a market cap or net worth of 1.77 billion as of March 25, 2026. Its market cap has decreased by -14.57% in one year.
Market Cap
1.77B
Enterprise Value
1.65B
Revenue
567.63M
Ranking
n/a
PE Ratio
31.70
Stock Price
190.50
Market Cap Chart
Since November 25, 2005, Stille AB's market cap has increased from 117.81M to 1.77B, an increase of 1,398.74%. That is a compound annual growth rate of 14.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.77B | 0.26% |
| Dec 30, 2025 | 1.76B | -5.77% |
| Dec 30, 2024 | 1.87B | 146.88% |
| Dec 29, 2023 | 757.04M | 34.82% |
| Dec 30, 2022 | 561.51M | -25.58% |
| Dec 30, 2021 | 754.53M | 69.88% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 124.23B |
| Getinge AB | 49.19B |
| Sectra AB | 42.43B |
| Medicover AB | 27.78B |
| Humana AB | 2.16B |
| Cereno Scientific AB | 1.97B |
| Egetis Therapeutics AB | 1.96B |
| Diamyd Medical AB | 1.87B |